New research suggests that younger generations are experiencing faster biological aging than their older counterparts, a trend that may explain the rising incidence of early-onset cancers. According to a study published in Nature Medicine, individuals with higher biological ages—a measure of how old the body appears compared to chronological age—face an increased risk of developing cancers at age 55 or younger, including lung, gastrointestinal, and uterine cancers.
The study, which analyzed data from more than 154,000 adults in the UK Biobank and over 10,000 participants in the U.S. National Institutes of Health’s (NIH) All of Us Research Program, establishes a direct link between accelerated systemic aging and the early emergence of solid tumors. As cancer rates among younger adults continue to climb globally, this research provides a new framework for understanding how cellular damage and environmental factors may be “biologically embedded” over time.
Understanding Biological Aging and Cancer Risk
Cancer is traditionally categorized as a disease of aging, with risk increasing as cells accumulate damage over decades. However, the recent shift toward younger diagnoses has prompted researchers to investigate whether this accumulation process is accelerating in more recent birth cohorts. The research team, led by scientists at Washington University School of Medicine in St. Louis, examined this by calculating an “age gap”—the difference between an individual’s chronological age and their biological age.
To quantify this, the researchers utilized established clinical biomarkers, including the PhenoAge and Klemera-Doubal Method, which track blood biochemistry markers like albumin and creatinine. They also employed a metabolomic age score to assess individual metabolic health. By comparing these markers across different birth cohorts, the team identified a distinct pattern: younger generations show a modest but consistent shift toward older biological profiles compared to older generations at the same chronological age.
For example, individuals in the UK born between 1965 and 1974 exhibited systemic aging that was 23% of one standard deviation higher than those born between 1950 and 1954. A more pronounced trend was observed in the U.S. cohort, where participants born between 1990 and 1999 showed systemic aging 92% of one standard deviation higher than those born between 1965 and 1969. This trend persists even after controlling for inherited genetic risks, suggesting that environmental and lifestyle factors play a significant role in the acceleration of the aging process.
Organ-Specific Aging and Tumor Development
Beyond systemic aging, the researchers looked at how specific organ systems age, using blood proteomic data to estimate biological decline within individual tissues. This granular approach revealed that accelerated aging in specific organs is associated with particular types of cancer. Advanced immune system aging, for instance, was linked to an increased risk of early-onset lung cancer, while accelerated aging in adipose (fat) tissue was associated with a higher risk of early-onset colorectal cancer.
“If we can identify younger people with the highest cancer risk when they are still healthy, we can focus on prevention and early-detection strategies for the individuals who will benefit most from early interventions,” said Yin Cao, a molecular epidemiologist and associate professor at Washington University School of Medicine, who co-leads Team PROSPECT under the Cancer Grand Challenges initiative. This initiative, co-founded by the National Cancer Institute and Cancer Research UK, aims to tackle the most complex challenges in cancer research.
When participants were categorized by their level of systemic aging, those with the most advanced biological aging faced a 15% higher risk of early-onset solid cancer compared to those with the least advanced aging.
Shifting the Paradigm for Cancer Prevention
The implications of this research extend to how clinicians might approach cancer screening in the future. Rather than relying solely on chronological age or inherited genetic risk, medical professionals may eventually use measures of biological aging to identify “high-risk” individuals in younger populations. This could allow for earlier interventions, such as tailored screening protocols or lifestyle modifications, before cancer develops.
Current research efforts, such as those led by Cao and her colleagues, are now focused on deciphering exactly how modern environments—including diet, sedentary behavior, metabolic dysregulation, and alcohol consumption—contribute to these biological imprints. By identifying these pathways, the goal is to shift the medical paradigm from reactive treatment to proactive, personalized prevention.
David Scott, director of Cancer Grand Challenges, noted the significance of the research scale: “Right now, we don’t have a definitive answer to what’s driving the rise of early-onset cancers around the world, but studies like this are helping us piece together the bigger picture, showing that cancer may be influenced not just by changes inside individual cells, but by wider changes happening across the body as a whole.”
The study was supported by a wide range of international organizations, including the National Cancer Institute of the NIH, the French National Cancer Institute, and the Bowelbabe Fund for Cancer Research UK. As researchers continue to map the relationship between accelerated biological aging and cancer susceptibility, the next frontier will be to develop tools that can reliably predict and mitigate these risks at the individual level.
Related reading